Monday, December 22, 2025
ADVT 
International

Indian-origin man admits to attacking cop in Singapore

Darpan News Desk IANS, 02 Jun, 2023 01:51 PM
  • Indian-origin man admits to attacking cop in Singapore

Singapore, June 2 (IANS) An Indian-origin man in Singapore admitted to attacking a police officer in 2020 and leaving him with a bloody face, a media report said.

Nikhil M. Durgude, 25, pleaded guilty on Thursday to eight charges including one for voluntarily causing hurt to deter a public servant from his duty, The Straits Times reported.

Also charged with possessing cannabis and consuming methamphetamine, Nikhil is expected to be sentenced on June 16.

According to court documents, three officers, including Senior Staff Sergeant Chua Ming Cheng and Inspector Zheng Yiyang, went to a unit at City Suites in Balestier as part of a police operation on November 5, 2020.

They identified themselves as police to Nikhil and his accomplices, Prakash Mathivanan and Malani Naidu Prabhakar.

After a while, Prakash lunged at Staff Sergeant Chua, causing him to fall. He then hit the officer in the face and upper body, the report said.

When Inspector Zheng pointed his revolver at Prakash asking him to stop attacking, the latter grabbed his hands.

Before Chua could get up and assist Inspector Zheng, he was attacked by Nikhil, who punched and kicked him repeatedly. He fell again and Nikhil continued to assault Chua as he lay on the floor, The Straits Times reported.

"The accused did so to prevent Staff Sergeant Chua from assisting Inspector Zheng, and intending, therefore, to deter Chua from discharging his duty as such public servant," the prosecution told the court

Nikhil stopped his attack on Chua when two other officers were led into the unit after some time.

The three men were arrested and taken to the Central Police Division headquarters where the authorities detected methamphetamine in Nikhil's urine after tests.

Staff Sergeant Chua suffered a cut on the forehead and abrasions on his right elbow and left forearm, and was admitted to Singapore General Hospital for treatment.

For voluntarily causing hurt to a public servant, Nikhil could be jailed for up to seven years, caned, or fined.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19